INmune Bio, Inc. (INMB)

NASDAQ: INMB · IEX Real-Time Price · USD
11.75
+0.12 (1.03%)
Mar 28, 2024, 4:00 PM EDT - Market closed

INmune Bio Market Cap

INmune Bio has a market cap or net worth of $209.59 million as of March 28, 2024. Its market cap has increased by 69.57% in one year.

Market Cap
209.59M
Enterprise Value
180.69M
1-Year Change
69.57%
Ranking
Category
Stock Price
$11.75

Market Cap Chart

Since February 4, 2019, INmune Bio's market cap has increased from $77.70M to $209.59M, an increase of 169.75%. That is a compound annual growth rate of 21.27%.

History

DateMarket Cap% Change
Mar 27, 2024209.60M-2.10%
Mar 26, 2024214.10M1.47%
Mar 25, 2024211.00M-4.05%
Mar 22, 2024219.90M2.37%
Mar 21, 2024214.80M2.82%
Mar 20, 2024208.90M5.93%
Mar 19, 2024197.20M-0.70%
Mar 18, 2024198.60M-0.35%
Mar 15, 2024199.30M-3.35%
Mar 14, 2024206.20M-3.10%
Mar 13, 2024212.80M0.42%
Mar 12, 2024211.90M0.33%
Mar 11, 2024211.20M-4.00%
Mar 8, 2024220.00M-2.35%
Mar 7, 2024225.30M-1.18%
Mar 6, 2024228.00M3.97%
Mar 5, 2024219.30M-5.39%
Mar 4, 2024231.80M3.81%
Mar 1, 2024223.30M6.79%
Feb 29, 2024209.10M-1.83%
Feb 28, 2024213.00M-2.38%
Feb 27, 2024218.20M-7.66%
Feb 26, 2024236.30M1.50%
Feb 23, 2024232.80M2.02%
Feb 22, 2024228.20M0.57%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
OptimizeRx 217.47M
908 Devices 217.21M
Acumen Pharmaceuticals 217.16M
Ovid Therapeutics 215.67M
AngioDynamics 215.22M
Merrimack Pharmaceuticals 214.05M
ASP Isotopes 213.14M
Vaxart 212.11M
Market Cap Rankings